India's drug landscape is witnessing a substantial rise in drug substance production houses. Fueled by increasing global requirement and supportive government guidelines, the country’s ingredient manufacturing domain has emerged as a vital contributor to the international healthcare network. This surge is creating several opportunities for fundin